| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |